Polymorphs of olanzapine hydrochloride
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 31, 2011
Grant Date -
Jan 4, 2007
app pub date -
Apr 22, 2004
filing date -
Apr 22, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to new crystalline forms I, II and III of 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]-benzodiazepine hydrochloride, a process for the preparation thereof and pharmaceutical compositions containing the same. Said new polymorphic forms are useful as active ingredients for the treatment of psychotic conditions.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully